Fagron NV

Brussels Stock Exchange FAGR.BR

Fagron NV Cash and Short-Term Investments for the year ending December 31, 2023: USD 151.52 M

Fagron NV Cash and Short-Term Investments is USD 151.52 M for the year ending December 31, 2023, a 12.99% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Fagron NV Cash and Short-Term Investments for the year ending December 31, 2022 was USD 134.10 M, a 66.75% change year over year.
Fagron NV Cash and Short-Term Investments for the year ending December 31, 2021 was USD 80.42 M, a -21.86% change year over year.
Fagron NV Cash and Short-Term Investments for the year ending December 31, 2020 was USD 102.91 M, a -14.04% change year over year.
Fagron NV Cash and Short-Term Investments for the year ending December 31, 2019 was USD 119.72 M, a 34.84% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Brussels Stock Exchange: FAGR.BR

Fagron NV

CEO	Mr. Rafael Padilla
IPO Date	Oct. 5, 2007
Location	Belgium
Headquarters	Venecoweg 20A
Employees	3,647
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Key trends

Past 5 years